Results for vasodilators translation from English to Maltese

vasodilators (peripheral)
vażodilataturi (periferali)

beta blockers, nitro-vasodilators,
imblokkaturi tar-riċetturi beta,

nitroglycerin and other nitrates, or other substances called “vasodilators”;
nitrogliċerina u nitrati oħra, jew sustanzi oħra msejħa “vażodilaturi”;

inhaled nitric oxide combination with other vasodilators acting by the cgmp or camp systems should be done with caution.
għandha tiġi eżerċitata l-kawtela jekk nitric oxide jintuża f’kombinazzjoni ma’ vażodilaturi oħrajn li jaġixxu fuq cgmp jew camp.

concomitant use with glyceryl trinitrate and other nitrates, or other vasodilators, may further reduce blood pressure.
l- użu konkomitanti ta ’ glyceryl trinitrate u nitrati oħra, jew vażodilaturi oħra, jista ’ jnaqqas aktar il- pressjoni tad- demm.

the concomitant use of alpha-blockers and vardenafil may lead to symptomatic hypotension in some patients because both are vasodilators.
l-użu ta’ alfa-blokers flimkien ma’ vardenafil jista jwassal għal pressjoni baxxa sintomatika f’uħud mill-pazjenti minħabba li t-tnejn huma vażodilataturi.

as with all other vasodilators, special caution is indicated in patients with aortic or mitral stenosis, or obstructive hypertrophic cardiomyopathy.
bħalma jiġri bis-sustanzi vażodilataturi l-oħrajn kollha, kawtela speċjali hi indikata f’pazjenti bi stenożi tal-aorta jew tal-mitrija, jew kardjomijopatija ipertrofika ostruttiva.

as with other vasodilators, special caution is indicated in patients suffering from aortic or mitral stenosis, or obstructive hypertrophic cardiomyopathy.
bħal fil-każ ta’ mediċini oħrajn li jwessgħu l-arterji/vini, għandha tingħata attenzjoni speċjali lil pazjenti li jbatu minn stenosi mitrali jew aortika, jew kardjomijopatija ipertropika ostruttiva.

however, cases of life threatening pulmonary oedema have been reported with vasodilators (mainly prostacyclin) when used in those patients.
madankollu, ġew rrappurtati każijiet ta’ edema pulmonari li tipperikola l-ħajja meta dawn il-pazjenti użaw vasodilaturi (prinċipalment prostcyclin).

vasodilators (used to widen blood vessels resulting from smooth muscle relaxation), or, if you are undergoing radiation therapy,
vażodilataturi (użati sabiex iwessgħu il-vini u l-arterji tad-demm li ġejjin minn rilassament tal- muskoli lixxi), jew, jekk għaddej minn terapija ta’ radjazzjoni,

cases of pulmonary oedema have been reported with vasodilators (mainly prostacyclins) when used in patients with pulmonary veno-occlusive disease.
każijiet ta’ edima pulmonari kienu rrapportati meta ntużaw mediċini li jwessgħu l-arterji/vini (l-aktar prostacyclins) meta użati f’pazjenti li għandhom marda fejn il-vini pulmonari jinsaddu.

patients with left ventricular outflow obstruction, e.g., aortic stenosis and idiopathic hypertrophic subaortic stenosis, can be sensitive to the action of vasodilators including type 5 phosphodiesterase inhibitors.
pazjenti li ġħandhom imblukkar tal-ħruġ mill-ventrikulu tax-xellug, eż., stenożi ta’ l-aorta, stenożi subaortika ipertrofika idjopatika, jistgħu jkunu sensittivi għall-azzjoni ta’ vażodilataturi inklużi impedituri ta’ phosphodiesterase tat-tip 5.

patients with left ventricular outflow obstruction, e.g. aortic stenosis and idiopathic hypertrophic subaortic stenosis, can be sensitive to the action of vasodilators, including pde5 inhibitors.
pazjenti li għandhom ostruzzjoni tal-passaġġ 'il barra tal- ventrikolu tax-xellug, eż. stenożi aortika u stenożi subaortika ipertrofika idjopatika, jistgħu jkunu sensittivi għall-azzjoni tal-vażodilataturi, inklużi l-inibituri ta’ pde5.

aortic and mitral valve stenosis, obstructive hypertrophic cardiomyopathy: as with other vasodilators, special caution is indicated in patients suffering from aortic or mitral stenosis, or obstructive hypertrophic cardiomyopathy.
stenożi tal-valv aortiku u mitrali, kardjomijopatija ipertrofika ostruttiva: bħal fil-każ ta’ vażodilatorji oħra, għandha tingħata attenzjoni speċjali f’pazjenti li jsofru minn stenożi aortika jew mitrali jew kardjomijopatija ipertrofika ostruttiva.

sildenafil has vasodilator properties, resulting in mild and transient decreases in blood pressure (see section 5.1).
sildenafil għandu karatteristiċi vażodilatatorji, li jirriżultaw fi tnaqqis ħafif u temporanju tal-pressjoni tad-demm (ara sezzjoni 5.1).